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We would like to thank Bosseau and Donal for their interest in our paper, and agree with 
them about the increasing clinical importance of patients with concomitant atrial fibrillation 
(AF) and heart failure, regardless of ejection fraction (1).  Indeed, our analysis confirms poor 
prognosis in patients suffering from AF and heart failure with preserved ejection fraction 
(HFpEF) and heart failure with reduced ejection fraction (HFrEF).  Although we identified 
higher crude rates of all-cause mortality with AF-HFrEF, incident stroke and heart failure 
admissions were similar to AF-HFpEF (2).   
Clearly these are different patient groups, as we confirmed in our article.  Patients with AF-
HFpEF were older, with more women and non-ischaemic cardiomyopathy, and this should be 
taken into account when considering outcomes in each group.  We also discussed the issues 
around adjusted mortality rates, particularly in light of these marked differences in 
characteristics.  As Bosseau and Donal note, if individual patient data were available and 
pooled for all studies, it is likely this would have reinforced the higher mortality in AF-
HFrEF.  Unfortunately, cause of death was not consistently reported in the contributing 
studies. 
The point regarding study type is well-taken and further registry data are welcomed.  
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However, we did perform a sensitivity analysis which showed that the excess mortality in 
AF-HFrEF compared to AF-HFpEF was also seen in cohort studies (risk ratio 1.21, 95% CI 
1.14-1.27), and this result was consistent across all subgroups (see Figure).  We believe that 
our findings are compatible with clinical experience and do not lessen the importance of 
HFpEF in AF.  In contrast, they highlight different treatment priorities compared to patients 
with concomitant HFrEF.  The impact of AF in heart failure patients (and vice-versa) has 
already been made clear from numerous published reports (3-8).  Our aim was rather to 
clearly define the differences in HFrEF and HFpEF in these patients, ensure better reporting 
in future studies and focus the mind of clinicians on the considerable impact that AF and 
heart failure have on quality of life and patient wellbeing (9,10). 
 
 
 
Figure: Summary of meta-analysis results; adapted from Kotecha et al. (2) 
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